Abstract:Objective Objectives To investigate the possible mechanism of procyanidin (PC) in regulating lipid metabolism through gut microbiota. Methods Male adult SD rats and Meriones unguiculatus were fed with basal forage for one week, of which the serum samples were collected and determined for total cholesterol (TC) level. These animals were divided into six groups according to their TC levels and bodyweights. The animals in normal control group were fed with common forage, while those in the other five groups with high lipid forage. The animals in three test groups were treated with PC by oral route at low (25 mg/kg), moderate (100 mg/kg) and high (150 mg/kg) dosages respectively, while those in positive control group with Fenofibrate at a dosage of 80 mg/kg, once a day for 8 (rats) and 2 (M. unguiculatus ) weeks. The rats were killed at end of 8 weeks, while M. unguiculatus at end of 2 weeks, of which serum samples were collected. However, the fecal samples of animals within 72 h before being killed were collected. The TC, triglyceride (TG), high density lipoproteinprotein cholesterol (HUlAl), low-density lipoprotein cholesterol (LDIy-C) and total bile acid (TBA) levels in sera were determined by full-automatic biochemical analyzer, while the TBA level in feces by enzymalic cycling assay kit, and the lecithin cholesterol acyl transferase (LCAT) activity by two-step double antibody sandwich ELISA. The histopathology of killed animals was observed. The genomic DNAs were extracted from bacteria in small intestines and intestinum caecum of the animals, and analyzed for the changes of predominant bacteria of gut microbiota by PCR-denaturing gradient gel electrophoresis (DGGE). Results The TC and TG levels of animals in model control group were significandy higher than those in normal control group (P< 0. 05), indicating successful establishment of animal model of hyperlipidemia. As compared with those in model control group, the serum TC, TG, LDL-C and TBA levels in three test groups decressed significantly, while LCAT activity and fecal TBA level increased significantly (each P < 0. 05). The liver lesion, hepatic cell swelling and degeneration in three test groups significantly improved. DGGE and imaging showed that the diversity of predominant bacteria from gut microbiota in three test groups increased significantly, while decreased significantly with the increasing dosage of TC. The bacterial profile of M. unguiculatus treated with 25 mg/kg PC was similar to that in model control group. However, the diversity of gut microbiota decreased significantly, and the predominant bacteria showed an obvious tendency of restoration, in 100 and 150 mg/kg group. Conclusion The predominant bacterial profile of gut microbiota of experimental animal model showed an obviouse tendency of restoration after intervention by PC and dosages of 100 and 150 mg/kg, indicating the PC might regulate the lipid metabolism via gut microbiota pathway.

Monascus ruber fermented Panax ginseng ameliorates lipid metabolism disorders and modulate gut microbiota in rats fed a high-fat diet

Procyanidin regulates lipid metabolism through gut microbiota

Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism

Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species

Rhamnogalacturonan-I enriched pectin from steamed ginseng ameliorates lipid metabolism in type 2 diabetic rats via gut microbiota and AMPK pathway

Modulation of the Gut Microbiota and Liver Transcriptome by Red Yeast Rice and Monascus Pigment Fermented by Purple Monascus SHM1105 in Rats Fed with a High-Fat Diet

Effects of fermented ginseng on the gut microbiota and immunity of rats with antibiotic-associated diarrhea

Ginsenoside Rb1, salvianolic acid B and their combination modulate gut microbiota and improve glucolipid metabolism in high-fat diet induced obese mice

Ameliorative effects of Monascus-fermented hawthorn extract on a high-fat diet-induced rat model of non-alcoholic fatty liver disease

Monascus red pigments alleviate high-fat and high-sugar diet-induced NAFLD in mice by modulating the gut microbiota and metabolites

Quantification of Panax Notoginseng Saponins Metabolites in Rat Plasma with in Vivo Gut Microbiota-Mediated Biotransformation by HPLC-MS/MS

Modulation of gut microbiota and lipid metabolism in rats fed high-fat diets by Ganoderma lucidum triterpenoids

Polymethoxyflavones in citrus extract has a beneficial effect on hypercholesterolemia rats by promoting liver cholesterol metabolism

Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility

Effects of (20 R)-Panaxadiol on NAFLD using non‐targeted metabolomics in stool

Ginseng polysaccharide components attenuate obesity and liver lipid accumulation by regulating fecal microbiota and hepatic lysine degradation

Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis

Personalized Bioconversion of Panax Notoginseng Saponins Mediated by Gut Microbiota Between Chinese-diet and Western-diet Healthy Subjects

Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation

Black Ginseng Extract Attenuates High-Fat Diet-Induced Obesity by Stimulating Ileal TGR5 Activation and Modulating Gut Microbiota

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis